Adaptive Biotechnologies Insider Sells $8.5 Million in Stock After Strong Performance
Harlan Robins, the chief scientific officer of Adaptive Biotechnologies (ADPT), sold $8.5 million worth of shares on July 2, 2026, following an 85% one-year total return for the stock. The sale was conducted under a Rule 10b5-1 trading plan and occurred at a price slightly above the recent market close.
Tickers: $ADPT